Balance Effects of Morton´s Extension in Flat Foot

NCT ID: NCT06526715

Last Updated: 2024-08-07

Basic Information

• Recruitment Status: COMPLETED
• Clinical Phase: NA
• Total Enrollment: 23 participants
• Study Classification: INTERVENTIONAL
• Study Start Date: 2024-07-30
• Study Completion Date: 2024-08-06

Brief Summary

The aim of this study is to simulate the orthopedic treatment called Morton's extension on flat foot patients to check balance effects in standing position.

Detailed Description

The objective of this study is to perform an assimilation of the orthopedic treatment called morton extension on flat foot patients to verify the balance with stabilometry study.

Conditions

Healthy Subjects

Study Design

• Allocation Method: NA
• Intervention Model: SINGLE_GROUP
• Primary Study Purpose: TREATMENT
• Blinding Strategy: NONE

Study Groups

Morton.s extension treatment

Appliation of Morton´s extension treatment simulation

Group Type: EXPERIMENTAL

Morton extension

Intervention Type: OTHER

A Morton extension with a height of 5 mm was insert from the proximal area of the first metatarsal head to the base of the proximal phalanx of the Hallux of the subjects' bare feet using a paper bandage. The material, shape, size, and thickness of the Morton Extension were the same.

Interventions

Morton extension

A Morton extension with a height of 5 mm was insert from the proximal area of the first metatarsal head to the base of the proximal phalanx of the Hallux of the subjects' bare feet using a paper bandage. The material, shape, size, and thickness of the Morton Extension were the same.

Intervention Type: OTHER

Eligibility Criteria

Inclusion Criteria

• Women and men aged 18 to 30 with flexible flat feet.

Exclusion Criteria

• Participants who have had any previous limb surgery, and/or previous lower limb trauma within the last year
• Uncorrected hearing or visual impairment.
• Lumbar pathology with radicular involvement.
• Pregnancy.
• Healthy participants performing strenuous exercise.
• Diagnosed active or inactive rheumatic or inflammatory disease.
• Participants consuming alcohol within 24 hours prior to recording or stimulants 6 hours prior to testing (e.g. caffeine).
• Participants who have a history of injury with residual lower extremity symptoms within the past year.
• Participants with evidence of a leg length discrepancy (difference in distance from the anterior superior iliac spine to the superior iliac spine at the surface of the most prominent aspect of the medial malleolus) of more than 1 cm 19
• Having at least 15 degrees of ankle dorsiflexion.
• Participants with evidence of balance deficit, as determined through oral questioning about falls and by use of the Balance Evaluation Systems Test (BESTest).
• Participants with neurological pathology with lower limb deformities, sensory-motor disturbances, neuromuscular pathology, or neurovascular disease.

• Minimum Eligible Age: 18 Years
• Maximum Eligible Age: 40 Years
• Eligible Sex: ALL
• Accepts Healthy Volunteers: Yes

Sponsors

Universidad de León

OTHER

Sponsor Role: collaborator

Mayuben Private Clinic

OTHER

Sponsor Role: lead

Responsible Party

EVA MARIA MARTÍNEZ JIMENEZ

Head of Podiatry, Principal Investigator, and Physiotherapist, profesor

Responsibility Role: PRINCIPAL_INVESTIGATOR

Principal Investigators

Eva María Martínez Jiménez, PhD

Role: PRINCIPAL_INVESTIGATOR

Universidad Complutense de Madrid

Locations

Eva María Martínez-Jiménez

León, , Spain

Countries

Spain

Other Identifiers

24/458-E

Identifier Type: -

Identifier Source: org_study_id